Last updated: 22 July 2019 at 12:03am EST

Dale G Ando Net Worth




The estimated Net Worth of Dale G Ando is at least $1.08 Million dollars as of 5 June 2015. Dale Ando owns over 15,000 units of Sangamo Therapeutics Inc stock worth over $93,881 and over the last 19 years Dale sold SGMO stock worth over $984,180.

Dale Ando SGMO stock SEC Form 4 insiders trading

Dale has made over 34 trades of the Sangamo Therapeutics Inc stock since 2012, according to the Form 4 filled with the SEC. Most recently Dale exercised 15,000 units of SGMO stock worth $51,750 on 5 June 2015.

The largest trade Dale's ever made was selling 20,000 units of Sangamo Therapeutics Inc stock on 26 October 2012 worth over $114,000. On average, Dale trades about 10,557 units every 25 days since 2005. As of 5 June 2015 Dale still owns at least 111,763 units of Sangamo Therapeutics Inc stock.

You can see the complete history of Dale Ando stock trades at the bottom of the page.



Insiders trading at Sangamo Therapeutics Inc

Over the last 24 years, insiders at Sangamo Therapeutics Inc have traded over $87,969,621 worth of Sangamo Therapeutics Inc stock and bought 3,434,008 units worth $48,483,268 . The most active insiders traders include Capital Management, L.P.Ra ..., Le Roy C Kopp, and Inc.Biogen Ma Inc. Biogen. On average, Sangamo Therapeutics Inc executives and independent directors trade stock every 21 days with the average trade being worth of $40,671. The most recent stock trade was executed by Inc.Biogen Ma Inc. Biogen on 26 September 2023, trading 6,000,000 units of SGMO stock currently worth $3,000,000.



What does Sangamo Therapeutics Inc do?

for sangamo therapeutics, science is a means to develop new medicines with the potential to transform the lives of patients living with serious genetic diseases. our scientists are leaders in the discovery, research and development of technologies enabling gene-based therapeutic development. currently we are conducting clinical trials, including the first ever in vivo human genome editing studies. to learn more about sangamo, visit the our website at www.sangamo.com.



Complete history of Dale Ando stock trades at Sangamo Therapeutics Inc

Insider
Trans.
Transaction
Total value
Dale G Ando
Vice President, Therapeutic Dev., and CMO
Option $51,750
5 Jun 2015
Dale G Ando
Vice President, Therapeutic Dev., and CMO
Option $51,750
5 May 2015
Dale G Ando
Vice President, Therapeutic Dev., and CMO
Option $51,750
6 Apr 2015
Dale G Ando
Vice President, Therapeutic Dev., and CMO
Option $51,750
5 Mar 2015
Dale G Ando
Vice President, Therapeutic Dev., and CMO
Option $91,500
5 Feb 2015
Dale G Ando
Vice President, Therapeutic Dev., and CMO
Option $102,300
5 Jan 2015
Dale G Ando
Vice President, Therapeutic Dev., and CMO
Option $102,300
5 Dec 2014
Dale G Ando
Vice President, Therapeutic Dev., and CMO
Option $83,850
5 Nov 2014
Dale G Ando
Vice President, Therapeutic Dev., and CMO
Option $61,650
6 Oct 2014
Dale G Ando
Vice President, Therapeutic Dev., and CMO
Option $61,650
5 Sep 2014
Dale G Ando
Vice President, Therapeutic Dev., and CMO
Sale $194,850
5 Aug 2014
Dale G Ando
Vice President, Therapeutic Dev., and CMO
Option $55,200
27 May 2014
Dale G Ando
Vice President, Therapeutic Dev., and CMO
Option $55,200
28 Apr 2014
Dale G Ando
Vice President, Therapeutic Dev., and CMO
Option $55,200
26 Mar 2014
Dale G Ando
Vice President, Therapeutic Dev., and CMO
Option $55,200
26 Feb 2014
Dale G Ando
Vice President, Therapeutic Dev., and CMO
Option $55,200
27 Jan 2014
Dale G Ando
Vice President, Therapeutic Dev., and CMO
Option $55,200
26 Dec 2013
Dale G Ando
Vice President, Therapeutic Dev., and CMO
Option $58,500
26 Nov 2013
Dale G Ando
Vice President, Therapeutic Dev., and CMO
Option $58,500
28 Oct 2013
Dale G Ando
Vice President, Therapeutic Dev., and CMO
Option $58,500
26 Sep 2013
Dale G Ando
Vice President, Therapeutic Dev., and CMO
Sale $150,600
26 Aug 2013
Dale G Ando
Vice President, Therapeutic Dev., and CMO
Sale $151,350
26 Jul 2013
Dale G Ando
Vice President, Therapeutic Dev., and CMO
Option $54,150
28 May 2013
Dale G Ando
Vice President, Therapeutic Dev., and CMO
Option $54,150
26 Apr 2013
Dale G Ando
Vice President, Therapeutic Dev., and CMO
Option $54,150
26 Mar 2013
Dale G Ando
Vice President, Therapeutic Dev., and CMO
Option $54,150
26 Feb 2013
Dale G Ando
Vice President, Therapeutic Dev., and CMO
Sale $100,640
26 Dec 2012
Dale G Ando
Vice President, Therapeutic Dev., and CMO
Sale $109,140
26 Nov 2012
Dale G Ando
Vice President, Therapeutic Dev., and CMO
Sale $114,000
26 Oct 2012
Dale G Ando
Vice President, Therapeutic Dev., and CMO
Sale $28,300
15 Oct 2012
Dale G Ando
Vice President, Therapeutic Dev., and CMO
Option $54,150
5 Sep 2012
Dale G Ando
Vice President, Therapeutic Dev., and CMO
Sale $25,900
27 Aug 2012
Dale G Ando
Vice President, Therapeutic Dev., and CMO
Sale $109,400
26 Jul 2012
Dale G Ando
Vice President, Therapeutic Dev., and CMO
Option $54,150
28 Jan 2012


Sangamo Therapeutics Inc executives and stock owners

Sangamo Therapeutics Inc executives and other stock owners filed with the SEC include: